CohBar Inc
(NASDAQ : CWBR)

( )
CWBR After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
AMGNAmgen Inc.
-0.83%191.561.2%$567.63m
GILDGilead Sciences, Inc.
-0.97%70.490.9%$501.34m
BIIBBiogen Inc.
-1.94%318.901.3%$457.42m
CELGCelgene Corporation
-4.05%71.021.2%$422.10m
ILMNIllumina, Inc.
-5.73%310.393.5%$402.00m
REGNRegeneron Pharmaceuticals, Inc.
-2.83%346.562.6%$291.08m
VRTXVertex Pharmaceuticals Incorporated
-4.27%172.851.9%$281.35m
ALXNAlexion Pharmaceuticals, Inc.
-3.92%118.602.0%$203.65m
AAgilent Technologies, Inc.
-4.12%64.501.5%$169.81m
LGNDLigand Pharmaceuticals Incorporated
-1.97%155.4723.3%$152.44m
EXASExact Sciences Corporation
-8.54%68.2525.3%$149.11m
SRPTSarepta Therapeutics, Inc.
-3.70%120.8216.4%$136.29m
ECYTEndocyte, Inc.
-0.04%23.552.0%$123.58m
INCYIncyte Corporation
-4.80%62.862.5%$111.57m
BMRNBioMarin Pharmaceutical Inc.
-2.72%93.074.3%$110.69m

Company Profile

CohBar, Inc. engages in the research and development of mitochondria-based therapeutics. It focuses on treatments of diseases, which include diabetes, obesity, fatty liver disease and non-alcoholic steatohepatitis, cancer, Alzheimer's disease, and atherosclerosis. The company was founded by Nir Barzilai, Pinchas Cohen, David Sinclair, John Amatruda, and Laura Cobb on October 19, 2007 and is headquartered in Pasadena, CA.